Angiologix Inc.

Ann Arbor's Everist Genomics Buys Angiologix Inc.Everest Genomics announced Monday it has completed the acquisition of 100 percent of the shares of Mountain View, Calif.-based Angiologix Inc., developer of the AngioDefender device for diagnosing heart and vein disease.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen